HEALTH● LOWSep 1 · Sep 1, 2026, 4:45 AM
Eli Lilly diabetes drug Mounjaro approved to reduce cardiovascular risks
businesstoday.in · India · global
The diabetes drug Mounjaro, developed by Eli Lilly, has been approved for its ability to reduce cardiovascular risks. This represents a significant advancement in treating diabetes and related heart conditions.
GlobeAlert aggregates and classifies open sources; the story above belongs to its publisher. Summaries are machine-generated from the source text.
More from India
POLITICS1h agoMarco Rubio India Visit to Focus on Business and Energy Tiessiliconindia.com · IndiaPOLITICS1h agoChina Strategic Reassessment of Indiawarontherocks.com · United StatesMILITARY1h agoMulti-purpose vessel INS Samarthak commissioned into Indian NavyThe HinduBUSINESS1h agoNon-tariff barriers are biggest hurdle in India-China trade, says Nirmala SitharamanThe Hindu
More in Health
HEALTH1h agoStates Pledge Meta $17 Billion Teen Social Media Settlement to Youth Mental Health , but Few Rules Bind Spendingmedicaldaily.com · United StatesHEALTH1h ago10 , 329 Oxfordshire patients faced ambulance delays in yearwitneygazette.co.uk · United KingdomHEALTH1h agoCan a positive mindset protect us from the sniffles?New ScientistHEALTH1h agoHong Kong private healthcare providers face new rules to make fees more transparentSouth China Morning Post